A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis

Completed · Phase 3

Conditions studied: Recurrent Herpes Simplex Labialis

In brief

Demonstrate the safety and efficacy of NB-001 in subjects with recurrent herpes labialis (RHL).

Key facts

Study ID
NCT01321359
Run by
NanoBio Corporation
People needed
907
Starts
2011-04-01
Expected to finish
2012-01-01
Last updated by the study team
2013-05-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.